LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a ...

During the last several years Mesa Laboratories has grown significantly in revenue and product line depth. As a result Mesa now has a much broader product line portfolio, significantly larger ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Mesa Laboratories, Inc. has a 12 month low of $83.68 and a 12 month high of $141.17. The stock’s 50 day moving average price is $120.47 and its 200 day moving average price is $116.30.

Captrust Financial Advisors acquired a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC.

For more information about the Company, please visit its website at CONTACT: CONTACT: Gary Owens; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc., +1-303-987-8000 ...

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and ...

About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, ...